ginkgolide b has been researched along with deoxycytidine in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Liu, C; Lou, C; Lu, H; Ma, Z; Zhang, Y | 1 |
1 other study(ies) available for ginkgolide b and deoxycytidine
Article | Year |
---|---|
Ginkgolide B enhances gemcitabine sensitivity in pancreatic cancer cell lines via inhibiting PAFR/NF-кB pathway.
Topics: Animals; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Deoxycytidine; Dose-Response Relationship, Drug; Drug Synergism; Fibrinolytic Agents; Gemcitabine; Ginkgolides; HEK293 Cells; Humans; Lactones; Mice; Mice, Nude; NF-kappa B; Pancreatic Neoplasms; Platelet Membrane Glycoproteins; Receptors, G-Protein-Coupled; Xenograft Model Antitumor Assays | 2019 |